Pharmaceutical dosage form for oral administration of a Bcl-2 family inhibitor

Details for Australian Patent Application No. 2010258367 (hide)

Owner Abbott GmbH & Co. KG

Inventors Packhaeuser, Claudia; Steiger, Norbert; Liepold, Bernd; Kostelac, Drazen; Knobloch, Martin

Agent Spruson & Ferguson

Pub. Number AU-A-2010258367

PCT Pub. Number WO2010/143074

Priority 61/185,130 08.06.09 US

Filing date 8 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 31/5377 (2006.01)

Event Publications

19 January 2012 PCT application entered the National Phase

  PCT publication WO2010/143074 Priority application(s): WO2010/143074

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258369-Protective routing of delimb cylinder hosing

2010258362-A system and method facilitating the purchase of goods and services by prepayment via universal gift or other prepaid card with incentives